Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract
Yuan Zhang, Juhura G. Almazi, Hui Xin Ong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2408-2408
Open Access | Times Cited: 24

Showing 24 citing articles:

Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges
Hara Kang, Yun Ji Ga, Soo Hyun Kim, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 49
Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment
Yonglong He, Wanting Zhang, Qingqing Xiao, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 6, pp. 817-837
Open Access | Times Cited: 35
Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses
Beatrice Tolksdorf, Julian Heinze, Daniela Niemeyer, et al.
Antiviral Research (2024) Vol. 226, pp. 105879-105879
Open Access | Times Cited: 5
In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2
Noha Samir Taibe, Sara H. Mahmoud, Maimona A. Kord, et al.
Computational and Structural Biotechnology Journal (2025)
Open Access
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2
Ellen Bowden-Reid, Scott Ledger, Yuan Zhang, et al.
Antiviral Research (2023) Vol. 217, pp. 105677-105677
Open Access | Times Cited: 14
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 4
Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery
Rushikesh Fopase, Chinmaya Panda, Amarnath P. Rajendran, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 7
Promising RNA-based therapies for Viral infections, Genetic Disorders and Cancer
Dickson Achimugu Musa, Mohammed Olumide Raji, Akeem Babatunde Sikiru, et al.
Academia molecular biology and genomics. (2024) Vol. 1, Iss. 1
Closed Access | Times Cited: 1
Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition
Shuai Wu, Ting Xiao, Hui Chen, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-18
Open Access | Times Cited: 1
RNA Interference Approach Is a Good Strategy against SARS-CoV-2
Ying‐Ray Lee, Huey‐Pin Tsai, Chun‐Sheng Yeh, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 100-100
Open Access | Times Cited: 7
Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines
Matteo Puccetti, Marilena Pariano, Aurélie Schoubben, et al.
Journal of Pharmacy and Pharmacology (2023) Vol. 76, Iss. 6, pp. 592-605
Closed Access | Times Cited: 3
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
Agustı́n Valenzuela-Fernández, Romina Cabrera-Rodríguez, Laura Ciuffreda, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 5
The Promising Therapeutic Potential of Oligonucleotides for Pulmonary Fibrotic Diseases
Divyani Paul, Madelyn Miller, Joshua R. Born, et al.
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 2, pp. 193-206
Open Access | Times Cited: 5
Anticipating the Next Chess Move: Blocking SARS-CoV-2 Replication and Simultaneously Disarming Viral Escape Mechanisms
Samir Mansour Moraes Casseb, André Salim Khayat, Jorge Estefano Santana de Souza, et al.
(2022)
Open Access | Times Cited: 4
Anticipating the Next Chess Move: Blocking SARS-CoV-2 Replication and Simultaneously Disarming Viral Escape Mechanisms
Samir Mansour Moraes Casseb, André Salim Khayat, Jorge Estefano Santana de Souza, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 2147-2147
Open Access | Times Cited: 4
Impact of Ebola virus nucleoprotein on VP40 virus-like particle production: a computational approach
Xiao Liu, Robert V. Stahelin, Elsje Pienaar
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Perspective Chapter: Mastering RNA Interference (RNAi) Delivery – Strategies for Effective Targeting and Gene Silencing
Ahmed Abosalha, Stephanie Makhlouf, Paromita Islam, et al.
IntechOpen eBooks (2024)
Closed Access
Potential activity of nanomaterials to combat SARS-CoV-2 and Mucormycosis ‎coinfection‎
Chinmaya Mahapatra, S. S. Jadhav, Prasoon Kumar, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-13
Closed Access
Targeted Delivery to Dying Cells Through P-Selectin–PSGL-1 Axis: A Promising Strategy for Enhanced Drug Efficacy in Liver Injury Models
Te-Sheng Lien, Der‐Shan Sun, Hsin‐Hou Chang
Cells (2024) Vol. 13, Iss. 21, pp. 1778-1778
Open Access
Improved Olfactory Deposition of Theophylline Using a Nanotech Soft Mist Nozzle Chip
M. Zhang, Frank Verhoeven, Pieter Ravensbergen, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
RNAi Degrades Spike Protein Gene Transcripts of the SARS-CoV-2 for Developing Drugs to Treat of COVID-19
Weiwei Zhang, Linjia Huang, Jumei Huang, et al.
Nano Biomedicine and Engineering (2022) Vol. 14, Iss. 2
Open Access | Times Cited: 1
In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2
Noha Samir Taibe, Sara H. Mahmoud, Maimona A. Kord, et al.
Research Square (Research Square) (2023)
Open Access
Impact of Ebola virus nucleoprotein on VP40 virus-like particle production: a computational approach
Xiao Liu, Robert V. Stahelin, Elsje Pienaar
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
An Effective Platform for SARS-CoV-2 Prevention by Combining Neutralization and RNAi Technology
Junxiang Zhou, Xue Yin, Haojun Liang
Chinese Journal of Polymer Science (2022) Vol. 41, Iss. 3, pp. 327-333
Open Access
Page 1

Scroll to top